[Effect of the antinoeplastic antibiotic 1719 from the group of diazo compounds on the immunological reactivity of the organism].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects; D000941:Antigens; D001391:Azo Compounds / Q000494:pharmacology*; D004912:Erythrocytes / Q000276:immunology; D004927:Escherichia coli Infections; D005973:Glutamine / Q000037:antagonists & inhibitors; D007109:Immunity / Q000187:drug effects*; D007114:Immunization; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects; D011817:Rabbits; D012756:Sheep / Q000276:immunology; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D000941:Antigens; D001391:Azo Compounds; D005973:Glutamine
Vliianie protivoopukholevogo antibiotika 1719 iz gruppy diazosoedineniĭ na immunologicheskogo reaktivnost' organizma.